Stocks

The table gives an overview of all stocks, alphabetically sorted.
 C Security CSEC Jan 20, 2020 0.31 +9.22   
 C-RAD B CRADB Jan 20, 2020 50.70 +0.20   
 CAG Group CAG Jan 20, 2020 72.00 +2.13   
 Calliditas Therapeutics CALTX Jan 20, 2020 84.00 -0.94   
 Calmark B CALMAB Jan 20, 2020 4.74 -7.96   
 Camanio Care CARE Jan 20, 2020 0.27 +1.87   
 Camurus CAMX Jan 20, 2020 92.20 +0.22   
 Cantargia CANTA Jan 20, 2020 18.90 +0.21   
 Capacent Holding CAPAC Jan 20, 2020 40.50 +0.25   
 Carbiotix CRBX Jan 20, 2020 6.00 0.00   
 Castellum CAST Jan 20, 2020 227.90 -0.57   
 Catella A CATA Jan 20, 2020 29.20 +1.39   
 Catella B CATB Jan 20, 2020 29.15 +4.67   
 Catena CATE Jan 20, 2020 425.00 -0.23   
 Catena Media CTM Jan 20, 2020 35.22 +0.40   
 Cavotec SA CCC Jan 20, 2020 20.50 +0.49   
 Cell Impact B CIB Jan 20, 2020 21.70 +24.71   
 CellaVision CEVI Jan 20, 2020 378.50 +6.02   
 CELLINK B CLNKB Jan 20, 2020 102.00 +4.08   
 Cereno Scientific B CRNOB Jan 20, 2020 3.64 +3.12   
 CGit B CGITB Jan 20, 2020 68.00 +23.64   
 Challenger Mobile B CHALB Jan 20, 2020 0.05 +22.50   
 Chordate Medical Holding CMH Jan 20, 2020 0.83 -9.78   
 Christian Berner Tech Trade B CBTTB Jan 20, 2020 29.30 -2.01   
 ChromoGenics CHRO Jan 20, 2020 0.48 -1.23   
 Cibus Nordic Real Estate CIBUS Jan 20, 2020 155.00 0.00   
 Cimco Marine CIMCO Jan 20, 2020 1.47 0.00   
 Clas Ohlson B CLASB Jan 20, 2020 108.00 0.00   
 Clavister Holding CLAV Jan 20, 2020 14.80 -0.67   
 Clean Motion CLEMO Jan 20, 2020 2.11 -14.23   
 


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.

Titlex

OK